[ Johnson & Johnson Innovation: Improving Detection of Neurotoxicity in Immunotherapies ]
Event details
| Date | 18.03.2022 |
| Category | Call for proposal |
Aim: Visionaries are invited to submit methods and technologies aiming to optimize patient care for immunotherapies within the hematologic malignancy space by enabling early detection of neurotoxic events. Of particular interest are technologies aiming to identify clinical manifestations to predict acute toxicities, including movement and neurocognitive disorders.
Amount: Increments up to $200,000, $125,000 or $75,000
Additional Perks: Access to the global Johnson & Johnson innovation – JLABS network and mentorship from experts at the Johnson & Johnson Family of Companies.
Deadline: 18 March 2022
Eligibility / Criteria: Potential solutions will be evaluated by an independent panel of reviewers and judges on their ability to meet the following criteria:
Click on the Apply now button just below the introductory photo on the following link: Improving Detection of Neurotoxicity in Immunotherapies
For further information:
Please contact the Research Office in the event you have questions or wish to apply to this opportunity.
Amount: Increments up to $200,000, $125,000 or $75,000
Additional Perks: Access to the global Johnson & Johnson innovation – JLABS network and mentorship from experts at the Johnson & Johnson Family of Companies.
Deadline: 18 March 2022
Eligibility / Criteria: Potential solutions will be evaluated by an independent panel of reviewers and judges on their ability to meet the following criteria:
- Accuracy in detecting and characterizing clinical manifestations, with a specific interest in variations in handwriting including micrographia, dysgraphia, and agraphia
- Patient accessibility
- Seamlessly integrates into healthcare settings and existing patient care model
- Feasibility and plans for deployment
- Potential impact
Click on the Apply now button just below the introductory photo on the following link: Improving Detection of Neurotoxicity in Immunotherapies
For further information:
Please contact the Research Office in the event you have questions or wish to apply to this opportunity.
Practical information
- General public
- Free